AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.2 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Publishing Language: Chinese | Open Access

Predictive value of electrocardiogram f-wave amplitude for 1-year recurrence after radiofrequency ablation in elderly patients with persistent atrial fibrillation

Qing YAN1, Shixin WANG2, Xin LI1, Linlin WANG3 ( ), Hongwu CHEN2, Minglong CHEN2
Department of Cardiology, Nanjing BenQ Medical Center, the Affiliated BenQ Hospital of Nanjing Medical University, Nanjing 210019
Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029
Department of Cardiology, the Fourth Affiliated Hospital of Soochow University, Suzhou 215000, China
Show Author Information

Abstract

Objective

To analyze the value of electrocardiogram (ECG) f-wave amplitude in predicting 1-year recurrence after radio frequency catheter ablation (RFCA) in elderly patients with persistent atrial fibrillation (PsAF).

Methods

Patients aged ≥60 years who were diagnosed with PsAF and underwent RFCA in the First Affiliated Hospital of Nanjing Medical University from September 2014 to May 2022 were enrolled. Based on 1-year follow-up, patients were divided into two groups: the recurrence group and the nonrecurrence group. The clinical characteristics of both groups were analyzed, and indicators showing significant differences were further examined using logistic regression analysis.

Results

A total of 369 patients were included, among which there were 281 cases (76.15%) in the non-recurrence group and 88 cases (23.85%) in the recurrence group. There were no significant differences between the two groups in terms of age, body mass index, comorbidities, left ventricular end diastolic dimension, left ventricular ejection fraction, pulmonary artery pressure, Pro-BNP, uric acid, and low-density lipoprotein cholesterol, antiarrhythmic drugs (all P > 0.05). Compared with the non-recurrence group, the recurrence group had higher female ratio (39.77% vs. 26.69%, P=0.019), a longer duration of atrial fibrillation [15.5 (6.00, 51.00) months vs. 9.00 (3.00, 24.00) months, P < 0.001], lower f-wave amplitude in lead Ⅲ [0.07 (0.06, 0.08) mV vs. 0.09 (0.08, 0.11) mV, P < 0.001], lead avF [0.06 (0.05, 0.07) mV vs. 0.08 (0.07, 0.10) mV, P < 0.001], and lead V2 [0.07 (0.06, 0.09) mV vs. 0.10 (0.08, 0.12) mV, P < 0.001], larger LAD [43.00 (40.25, 46.00) mm vs. 42.00 (40.00, 45.00) mm, P=0.039] and RAD [41.00 (39.00, 43.75) mm vs. 40.00 (39.00, 42.00) mm, P=0.038]. Logistic regression analysis identified atrial fibrillation duration as a risk factor for recurrence in elderly patients, while f-wave amplitudes in lead V2 and avF were independently negatively correlated with 1-year recurrence after radiofrequency ablation.

Conclusion

The ECG f-wave amplitudes and atrial fibrillation duration may serve as predictors of the outcome of RFCA in elderly patients with PsAF.

CLC number: R541.75 Document code: A Article ID: 1007-4368(2026)09-1341-08

References

【1】
【1】
 
 
Journal of Nanjing Medical University (Natural Sciences)
Pages 1341-1347

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
YAN Q, WANG S, LI X, et al. Predictive value of electrocardiogram f-wave amplitude for 1-year recurrence after radiofrequency ablation in elderly patients with persistent atrial fibrillation. Journal of Nanjing Medical University (Natural Sciences), 2026, 46(9): 1341-1347. https://doi.org/10.7655/NYDXBNSN250740

5

Views

0

Downloads

0

Crossref

Received: 02 July 2025
Revised: 04 November 2025
Accepted: 04 December 2025
Published: 15 September 2026
© 2026 Editorial Board of Journal of Nanjing Medical University(Natural Sciences)

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).